We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Neukio

News List

EdiGene and Neukio enter collaboration to develop next-generation immune cell therapies ExpressPharma
February 14, 2022
EdiGene, Inc and Neukio Biotherapeutics have announced an R&D collaboration to develop next-generation immune cell therapies, Neukio Biotherapeutics informed via a statement.
Neukio Biotherapeutics completed its $40m Angel round financing, focusing on the development of iPSC-CAR-NK platform and assets. prnasia
July 30, 2021
Neukio Biotherapeutics, a newly established company, recently announced the completion of its $40m Angel round of financing led by Lilly Asia Venture (LAV), with the participation of IDG Capital and Sherpa Investments.